Clinical and correlative results of SWOG S0354: a phase II trial of CNTO328 (siltuximab), a monoclonal antibody against interleukin-6, in chemotherapy-pretreated patients with castration-resistant prostate cancer
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Nicholas J. Vogelzang David I Quinn |
| Publication date | May 18, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |